Getting a bone marrow transplant starts with a referral from your doctor to a specialized transplant center, where a team evaluates whether the procedure is the right treatment for your condition. The process from initial evaluation to recovery typically spans several months and involves finding a donor (if you need one), undergoing intensive conditioning treatment, receiving the transplant itself, and waiting for your body to begin producing healthy blood cells again. Here’s what each stage looks like in practice.
Conditions That Lead to a Transplant
Bone marrow transplants are most commonly used for blood cancers and serious blood disorders. The conditions that benefit most include leukemia, lymphoma, multiple myeloma, severe aplastic anemia, sickle cell anemia, and immune deficiency disorders. In rare cases, certain solid tumors may also be treated this way. The procedure has been used successfully since 1968.
Your transplant team will weigh several factors before recommending the procedure: your age, overall health, the stage and severity of your disease, how well you’ve responded to other treatments, and whether a suitable donor is available. Not everyone with these conditions needs a transplant, and for some patients, the risks may outweigh the benefits depending on their individual situation.
Two Main Types of Transplant
In an autologous transplant, your own stem cells are collected and stored before you undergo high-dose treatment, then infused back into your body afterward. This is more common for lymphoma, multiple myeloma, and some solid tumors. The advantage is that there’s no need to find a matched donor and no risk of your body rejecting the cells.
In an allogeneic transplant, the stem cells come from another person, either a family member or an unrelated donor. This type is used predominantly for leukemias and related blood disorders. It has the advantage of providing cells free of any lingering cancer, and the donor’s immune cells can actually help fight remaining disease in your body, a phenomenon called the graft-versus-malignancy effect. The tradeoff is a higher risk of complications, particularly graft-versus-host disease.
Finding a Donor
If you need an allogeneic transplant, the search for a compatible donor is one of the most critical steps. Compatibility is determined by matching proteins on the surface of your cells called HLA markers. For a sibling donor, doctors look for a match at 6 out of 6 key markers. For an unrelated adult donor, the standard is an 8 out of 8 match at four specific marker locations. Umbilical cord blood units require a minimum 4 out of 6 match, which makes them a more flexible option when a perfect adult donor isn’t available.
A full sibling has roughly a 25% chance of being a perfect match. When no matched family member exists, your transplant center initiates a search through the National Marrow Donor Program (NMDP) registry, which contains millions of volunteer donors worldwide. The process works in stages: your doctor first requests a preliminary search comparing your HLA type against the registry. If potential matches appear, the transplant center orders additional blood testing on one or more candidates to confirm compatibility. Donors who appear to be a good match are then contacted to confirm they’re healthy, willing, and able to donate.
If no fully matched donor is found, a half-matched (haploidentical) family member, often a parent, child, or sibling, may be an option. These donors need to match at least 4 out of 8 HLA markers. Advances in transplant techniques have made haploidentical transplants increasingly viable, broadening access for patients who previously had no donor options.
Getting Evaluated at a Transplant Center
If you’re not already at a transplant center, your doctor will refer you to one. These are specialized hospitals with the infrastructure and expertise to perform transplants safely. Many patients have to travel significant distances, and some need to temporarily relocate with a caregiver to be near the center for the duration of treatment and early recovery.
During evaluation, your transplant team runs a battery of tests to assess your organ function, infection status, and overall fitness for the procedure. They’ll also review your insurance coverage. Most insurance companies require preauthorization before transplant services can begin, so expect paperwork and phone calls between your transplant center and your insurer. You’ll be responsible for any costs your insurance doesn’t cover, so it’s worth understanding your out-of-pocket obligations before treatment starts.
Conditioning: Preparing Your Body
Before you receive new stem cells, your body needs to be prepared through a process called conditioning. This involves chemotherapy, radiation, or a combination of both, and serves two purposes: destroying diseased or cancerous cells in your bone marrow and suppressing your immune system enough to accept the new cells.
The intensity of conditioning varies. Myeloablative (full-intensity) regimens completely wipe out your existing bone marrow using high-dose chemotherapy or total body irradiation. These are more effective at eliminating disease but are also harder on your body. Reduced-intensity and nonmyeloablative regimens use lower doses, relying more on the donor’s immune cells to fight remaining disease over time. These gentler approaches have made transplants possible for older patients and those with other health concerns who couldn’t tolerate full-intensity treatment.
Conditioning typically lasts about a week, though the exact duration depends on your specific regimen. You’ll be in the hospital during this time, and side effects like nausea, fatigue, mouth sores, and hair loss are common.
The Transplant Itself
The actual transplant is surprisingly undramatic. It looks and feels much like a blood transfusion. If the donated marrow or stem cells were frozen, they’re thawed first. Then the cells are infused through an IV line, usually over the course of a few hours. The day of infusion is called “Day 0” on the transplant timeline, with everything before it counted in negative numbers and everything after in positive numbers.
Once in your bloodstream, the stem cells travel to your bone marrow on their own and begin producing new blood cells. You won’t feel this happening. What you will feel during the days and weeks after is the deep fatigue and vulnerability that comes from having essentially no functioning immune system while you wait for the new marrow to take hold.
Engraftment and Early Recovery
The period after infusion is the most physically demanding part of the process. Your blood counts drop to dangerously low levels, leaving you highly susceptible to infection and bleeding. You’ll remain in the hospital or in very close proximity to the transplant center during this time, receiving blood and platelet transfusions as needed and taking medications to prevent infection.
Engraftment, the point at which the transplanted cells begin producing new blood cells, typically happens about 7 to 12 days after Day 0. The first sign your team watches for is a rising neutrophil count, since neutrophils are the white blood cells that fight bacterial infections. Red blood cell and platelet counts take a few more weeks to normalize. Once you no longer need frequent transfusions, you may be able to go home, though you’ll still need regular follow-up visits.
Graft-Versus-Host Disease
The most significant complication of allogeneic transplants is graft-versus-host disease (GVHD), where the donor’s immune cells attack your tissues, recognizing them as foreign. Acute GVHD, occurring in the first few months, affects roughly 39% of patients with sibling donors and 59% with unrelated donors. Severe forms develop in about 10 to 30% of patients, though modern prevention strategies have brought severe cases down to 10% or less at many centers.
GVHD most commonly targets the skin, liver, and digestive tract. Symptoms can range from a mild rash to serious organ damage. To reduce this risk, patients receiving allogeneic transplants are given immune-suppressing medications starting around the time of transplant. Chronic GVHD, a longer-lasting form that can develop months to years later, occurs in 25 to 80% of patients depending on the type of transplant and prevention strategy used. It can affect the skin, eyes, mouth, lungs, and joints, sometimes requiring treatment for years.
Long-Term Outlook
Survival after a bone marrow transplant depends heavily on the underlying disease, your age, the type of transplant, and how well your body responds. For patients with acute leukemia who survive at least two years post-transplant, the outlook improves substantially. Among these two-year survivors, overall survival at five years reaches about 88 to 90%, and at ten years around 76 to 81%. The risk of the original disease returning remains present but decreases over time.
Full recovery is a gradual process that can take a year or longer. Your immune system rebuilds slowly, and you’ll need to take precautions against infection for months. Many transplant centers schedule follow-up visits frequently during the first year, then less often as your health stabilizes. Fatigue, changes in appetite, and emotional adjustment are all normal parts of the recovery period.